NCT06375915

Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological Therapy

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2024-04-30Est. Completion: 2027-05

Enrollment target: 33 participants

Locations

ASST Papa Giovanni XXIII, Bergamo, Bg, Italy
Azienda Ospedaliero Universitaria Pisana, Pisa, Pi, Italy
Department of Radiology, IRCCS Ospedale San Raffaele, Milan, Italy
Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli, Naples, Italy

Other microbiome trials you might be interested in

Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or CholangiocarcinomaPhase 2Recruiting

Locally Advanced Ampulla of Vater CarcinomaLocally Advanced Biliary Tract CarcinomaLocally Advanced Extrahepatic CholangiocarcinomaLocally Advanced Gallbladder CarcinomaLocally Advanced Intrahepatic CholangiocarcinomaMetastatic Ampulla of Vater CarcinomaMetastatic Biliary Tract CarcinomaMetastatic Extrahepatic CholangiocarcinomaMetastatic Gallbladder CarcinomaMetastatic Intrahepatic CholangiocarcinomaStage III Ampulla of Vater Cancer AJCC v8Stage III Distal Bile Duct Cancer AJCC v8Stage III Gallbladder Cancer AJCC v8Stage III Intrahepatic Cholangiocarcinoma AJCC v8

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.